Research
Print page Print page
Switch language
Glostrup Hospital - a part of Copenhagen University Hospital

Published

Genetic Variation in the Natriuretic Peptide System, Circulating Natriuretic Peptide Levels, and Blood Pressure : An Ambulatory Blood Pressure Study

Publication: Research - peer-reviewJournal article

Harvard

APA

CBE

MLA

Vancouver

Author

Jeppesen, Jørgen L; Nielsen, Søren J; Torp-Pedersen, Christian; Hansen, Tine W; Olsen, Michael H; Berg, Nikolaj D; Linneberg, Allan; Madsbad, Sten; Fenger, Mogens / Genetic Variation in the Natriuretic Peptide System, Circulating Natriuretic Peptide Levels, and Blood Pressure : An Ambulatory Blood Pressure Study.

In: American Journal of Hypertension, Vol. 25, No. 10, 2012, p. 1095-1100.

Publication: Research - peer-reviewJournal article

Bibtex

@article{282a90af06ff4d6cb3068f1d3acdb368,
title = "Genetic Variation in the Natriuretic Peptide System, Circulating Natriuretic Peptide Levels, and Blood Pressure",
publisher = "Nature Publishing Group",
author = "Jeppesen, {Jørgen L} and Nielsen, {Søren J} and Christian Torp-Pedersen and Hansen, {Tine W} and Olsen, {Michael H} and Berg, {Nikolaj D} and Allan Linneberg and Sten Madsbad and Mogens Fenger",
year = "2012",
volume = "25",
number = "10",
pages = "1095--1100",
journal = "American Journal of Hypertension",
issn = "0895-7061",

}

RIS

TY - JOUR

T1 - Genetic Variation in the Natriuretic Peptide System, Circulating Natriuretic Peptide Levels, and Blood Pressure

T2 - An Ambulatory Blood Pressure Study

A1 - Jeppesen,Jørgen L

A1 - Nielsen,Søren J

A1 - Torp-Pedersen,Christian

A1 - Hansen,Tine W

A1 - Olsen,Michael H

A1 - Berg,Nikolaj D

A1 - Linneberg,Allan

A1 - Madsbad,Sten

A1 - Fenger,Mogens

AU - Jeppesen,Jørgen L

AU - Nielsen,Søren J

AU - Torp-Pedersen,Christian

AU - Hansen,Tine W

AU - Olsen,Michael H

AU - Berg,Nikolaj D

AU - Linneberg,Allan

AU - Madsbad,Sten

AU - Fenger,Mogens

PB - Nature Publishing Group

PY - 2012

Y1 - 2012

N2 - BackgroundIn a large collaborative study (n > 50,000), common variants in the natriuretic peptide (NP) genes were found to be associated with circulating NP levels and also with blood pressure (BP) levels based on office BP measurements (OBPMs). It is unknown if determining an individual's BP by 24-h ambulatory BP measurements (ABPMs) will influence the effect of NP gene variations on BP levels.MethodsWe used rs632793 at the NPPB (NP precursor B) locus to investigate the relationship between genetically determined serum N-terminal pro-brain NP (NT-proBNP) concentrations and BP levels determined by both 24-h ABPMs and OBPMs in a population consisting of 1,397 generally healthy individuals taking no BP-lowering drugs.Resultsrs632793 was significantly correlated with serum Nt-proBNP levels (r = 0.10, P = 0.0003), and participants with the A:A genotype had lower serum Nt-proBNP levels than participants with the G:G genotype (geometric mean (95% confidence interval (CI)): 34.8 (31.5-38.4) pg/ml vs. 48.1 (41.9-55.3) pg/ml, P = 0.0002), but higher 24-h ambulatory BP levels (mean difference (95% CI): 2.0 (0.1-4.1) mm Hg, P = 0.043, for systolic BP and 1.7 (0.4-3.1) mm Hg, P = 0.011, for diastolic BP). Office BP decreased across the genotypes from A:A to G:G, but the differences did not reach statistical significance (P ≥ 0.12).ConclusionsThis study suggests that 24-h ABPMs is a better method than OBPMs to detect significant differences in BP levels related to genetic variance and provides further evidence that the NP system plays an important role in BP regulation.American Journal of Hypertension 2012; doi:10.1038/ajh.2012.96.

AB - BackgroundIn a large collaborative study (n > 50,000), common variants in the natriuretic peptide (NP) genes were found to be associated with circulating NP levels and also with blood pressure (BP) levels based on office BP measurements (OBPMs). It is unknown if determining an individual's BP by 24-h ambulatory BP measurements (ABPMs) will influence the effect of NP gene variations on BP levels.MethodsWe used rs632793 at the NPPB (NP precursor B) locus to investigate the relationship between genetically determined serum N-terminal pro-brain NP (NT-proBNP) concentrations and BP levels determined by both 24-h ABPMs and OBPMs in a population consisting of 1,397 generally healthy individuals taking no BP-lowering drugs.Resultsrs632793 was significantly correlated with serum Nt-proBNP levels (r = 0.10, P = 0.0003), and participants with the A:A genotype had lower serum Nt-proBNP levels than participants with the G:G genotype (geometric mean (95% confidence interval (CI)): 34.8 (31.5-38.4) pg/ml vs. 48.1 (41.9-55.3) pg/ml, P = 0.0002), but higher 24-h ambulatory BP levels (mean difference (95% CI): 2.0 (0.1-4.1) mm Hg, P = 0.043, for systolic BP and 1.7 (0.4-3.1) mm Hg, P = 0.011, for diastolic BP). Office BP decreased across the genotypes from A:A to G:G, but the differences did not reach statistical significance (P ≥ 0.12).ConclusionsThis study suggests that 24-h ABPMs is a better method than OBPMs to detect significant differences in BP levels related to genetic variance and provides further evidence that the NP system plays an important role in BP regulation.American Journal of Hypertension 2012; doi:10.1038/ajh.2012.96.

U2 - 10.1038/ajh.2012.96

DO - 10.1038/ajh.2012.96

JO - American Journal of Hypertension

JF - American Journal of Hypertension

SN - 0895-7061

IS - 10

VL - 25

SP - 1095

EP - 1100

ER -

ID: 35985129